We can all agree that the past week has been a rollercoaster ride for traders. With major US stock market indexes experiencing drops ranging from -0.71 percent to -3.63 percent, it's clear that navigating market turbulence demands a sophisticated trading approach. That's why we're excited to introduce Tickeron's best-performing algorithm of the week, a true beacon of stability and consistent results.
Swing Trader: Medium Volatility Stocks for Active Trading (TA&FA)
Click to view full description and closed trades for free!
In times of sharp corrections like these, the ability to accurately assess market volatility and manage risks effectively becomes paramount. Tickeron's cutting-edge algorithm is precisely crafted to do just that, offering you the confidence you need in today's challenging trading environment.
What sets our top robot apart is its remarkable Sharpe ratio of 1.7, a testament to its ability to deliver consistent returns while efficiently managing risk. This stability and reliability are what every trader seeks, especially in unpredictable markets.
Click to view full description and closed trades for free!
Key highlights of Tickeron's top-performing algorithm:
Navigating the market's ups and downs requires a trusted companion by your side, and Tickeron's algorithm is that reliable partner. It excels in identifying opportunities while protecting your investments, allowing you to focus on your trading strategies without the anxiety of market volatility.
Stay ahead of market turbulence with Tickeron - your path to stability and consistent results!
Here are the latest trades:
The Moving Average Convergence Divergence (MACD) for SAVA turned positive on April 15, 2025. Looking at past instances where SAVA's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SAVA's RSI Indicator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on May 08, 2025. You may want to consider a long position or call options on SAVA as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where SAVA advanced for three days, in of 247 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SAVA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
SAVA broke above its upper Bollinger Band on May 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for SAVA entered a downward trend on April 22, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.670) is normal, around the industry mean (14.691). P/E Ratio (0.000) is within average values for comparable stocks, (62.716). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.861). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (253.146).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SAVA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SAVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of novel drugs
Industry Biotechnology